Introduction
The advent of prostate-specific antigen (PSA) and the ability to safely and accurately biopsy the prostate as an outpatient procedure coupled with increased public awareness has led to a dramatic increase in the incidence of prostate cancer in the Western world over the last 10 years. 1 In addition to its use in the diagnosis of prostate cancer, PSA is also widely used as a tumour marker in the monitoring of patients. 2 This is true for determining the effectiveness or response to treatment or the failure of treatment with a rising PSA signifying a recurrence of the cancer or the development of hormone resistance.
Monitoring patients by PSA, however, is not without problems. Biological variability 3 makes it necessary to judge the rate of rise by serial values. As prostate cancer is frequently a slowly growing cancer, measurements may have to be made over many years. In addition, PSA screening is detecting many cancers that may not be a threat to the patient with many patients dying of an unrelated disease. 4 Such patients may undergo active surveillance with treatment deferred until signs of tumour progression. 5 One of the main factors that determine the likelihood of the development of metastatic disease is the PSA doubling time. 6 As patients with prostate cancer are detected earlier in their disease, this means that increasing numbers of patients are requiring more and more clinic time to review them. This has cost implications for burgeoning clinics and also has knock on effects on the time that is available to counsel new patients who have important decisions to make about treatment options or who require additional treatment when they have recurrent disease.
Many patients come to the clinic simply to be reassured that their PSA value is satisfactory without requiring examination. This is inconvenient, time-consuming and in some cases expensive for patients, as the costs of public transport and parking rise, for a simple task that could be done over the phone. To address these issues, we have set up a nurse-led telephone-based consultation for patients on routine PSA surveillance.
The concept of telephone consultations is not a new one. In 1992, a randomised controlled trial of one outpatient clinic compared telephone consultations with outpatient visits for older patients with chronic diseases. 7 The researchers found there was no detrimental effect on health outcomes and there was a significant reduction in costs and the use of resources. Other studies have demonstrated acceptable use of telephone consultations in settings as wide ranging as follow-up after laparoscopic cholecystectomy 8 and identification of wound infection after elective joint replacement. 9 However, not all studies have shown positive outcomes, with the main deficiency in one study appearing to be the fact that telephone consultations became an additional service rather than a method of reducing outpatient clinic resource use. 10 Given the increasing use of telephone consultations in a variety of situations, it is perhaps surprising that relatively few studies have evaluated its use in urological situations. In terms of prostate cancer, a recent study from the UK looked at the satisfaction levels of 36 patients who had undergone radiotherapy with a nurseled telephone-based follow-up and found that the majority of men were satisfied with their care. 11 These findings are backed up by a study looking at the outcome measures of satisfaction with regard to waiting times, information given to patients regarding their PSA results and level of service received from a nurse-led clinic. 12 Apart from providing routine follow-up, telephone consultations have also been used as a therapeutic tool in the management of prostate cancer. In the USA, nurseled telephone consultations for patients with prostate cancer have been shown to reduce the degree of patients' uncertainty about their condition and improve their quality of life, 13 although a number of other factors such as patient's education and degree of reinforcement of information play a significant part.
14 In addition, after radical treatment, nurse-led consultations have been demonstrated to reduce the number of side effects experienced by patients. 15 In this study, we set out to determine the level of patient satisfaction with nurse-led telephone consultations for patients with prostate cancer, comparing these levels with traditional outpatient-based follow-up. In addition, we recorded a number of other variables such as duration and waiting time for the consultation for each group, and looked at the impact of telephone consultation on these variables.
Methods
To measure patients' satisfaction with the consultation rather than with other aspects of the outpatient visit (such as cleanliness of the department, attitude of administrative staff, etc.), we used the Consultation Satisfaction Questionnaire (CSQ). This was originally developed in 1990, and has been validated for use in assessing patients' satisfaction with their consultation in a primary care setting. 16, 17 The questionnaire consisted of 18 questions to which there were five possible responses on a Likert scale (see Appendix A). The questionnaire evaluated four separate domains, namely General Satisfaction (GS), Professional Care (PC), Depth of Relationship (DR) and Perceived Time of consultation (PT). In addition, we asked a series of other questions relating to the distance travelled to clinic (for the outpatient group), the cost involved, the duration of the consultation and the waiting time in the clinic to determine the effect of starting telephone consultations on these parameters (see Appendix B).
Over a 10-week period between October and December 2004, before commencing the telephone consultations, we asked all patients attending the prostate cancer follow-up clinic to complete the questionnaire (Group 1 outpatients) immediately after their consultation. After the telephone consultations commenced, patients who attended the prostate cancer follow-up clinic either because they had been referred following a telephone consultation, were newly diagnosed patients, or patients whom it was felt would need to be seen face to face (e.g. the first postoperative consultation after radical treatment) were also asked to complete the questionnaire (Group 2 outpatients) immediately after their consultation. If they had already completed a questionnaire in the outpatient department (as part of Group 1 outpatients), they were not asked to fill in a second questionnaire.
Once the telephone consultations began in January 2005, we sent the questionnaire by post to all patients undergoing this method of consultation (Group 3 telephone), asking them to fill in the questionnaire immediately after their telephone consultation and return it to us by post. Patients who expressed a desire to be seen face to face or patients whom the clinician thought needed to be seen face to face were asked to attend the outpatient department the following week. The vast majority of the telephone consultations were carried out by nurse specialists, although the remainder were carried out by members of the medical team. The same questionnaire was used for both nurse-and doctorled consultations to maintain consistency across the comparison groups.
Incomplete questionnaires were handled as suggested in the CSQ manual, which enabled some of the domains to be calculated even if the questionnaire was incomplete. Results were collated and analysed using SPSS v.11.
Results
For the initial group approached in outpatients before commencement of the telephone consultations (Group 1 outpatients), we received a total of 299 useable questionnaires from 364 patients approached (response rate, 82.1%). For the second group approached in outpatients after the commencement of the telephone consultation (Group 2 outpatients), we received 163 completed questionnaires from 218 patients approached (response rate, 74.7%). We received a total of 234 questionnaires from 553 sent to those undergoing the telephone consultation (Group 3 telephone), a response rate of 42.3% (predictably lower than in Groups 1 and 2, as these questionnaires had to be returned by mail). Internal consistency of the questionnaire for use in this sample was assessed by calculating the Cronbach alpha score. The overall alpha score was a satisfactory 0.73. 18 The mean percentage score for each of the four domains of the CSQ, namely GS, PC, DR and PT for each of the three groups are shown in Table 1 .
For Group 1 (Seen in Outpatients before commencing telephone consultation), the mean distance travelled was 8.6 miles. The mean cost of the journey was d2.67. The 14 were newly diagnosed and seen to discuss treatment options, three had been diagnosed at transurethral resection of the prostate (TURP) and were seen to discuss the need for peripheral zone biopsies and two patients had received cryotherapy in another centre. For Group 2 (Seen in Outpatients after commencing telephone consultation), the mean distance travelled was 8.9 miles. The mean cost was d4.77. 80.4% travelled privately, with 11.6% using public transport and 6.7% walking. 91.2% made a direct trip. 15.3% found the trip inconvenient. To email 44.0% had access. The mean time from leaving home to see the clinician was 86.3 min. In contrast to Group 1, 36.8% of patients were examined. The mean duration of consultation was 17.7 min and the mean waiting time was 27.2 min. All 163 patients were examined by physicians. In this group, 20 patients (12.3%) had received initial radiotherapy, 33 (20.2%) had undergone radical prostatectomy, 34 (20.9%) were on active surveillance and 54 (33.1%) were treated with hormones. Of the remaining 22 men, 19 were newly diagnosed and examined to discuss treatment options, two had undergone high-intensity focused ultrasound in another centre and one had undergone cryotherapy elsewhere.
For Group 3 (Those who had a telephone consultation), there was no need for the patient to travel; nevertheless, the mean distance the patients lived from the hospital was 9.66 miles. When asked if they thought a visit to the hospital would be inconvenient, 47.1% replied in the affirmative, 34.9% had access to email at home and 14.3% were required to attend the outpatient department the following week, either at their request or because the clinician felt it was required. The mean duration of consultation was 7.2 min and the mean waiting time was 1.4 min. Two hundred and fifteen (91.9%) of the telephone consultations were performed by nurses with the remainder performed by physicians. Fifty-six men (23.9%) initially had radiotherapy, 46 (19.7%) had undergone radical prostatectomy, 82 (35.0%) were on active surveillance and 50 (21.4%) were initially treated with hormones.
There was no statistically significant difference in GS between Groups 1 and 3 (P ¼ 0.72) nor was there any difference in PC (P ¼ 0.58); however, there was a significant difference in DR (P ¼ 0.01) and PT (P ¼ 0.02). The telephone consultations were significantly shorter than in Group 1 (Po0.01) as was the waiting time (Po0.01).
A similar pattern emerges in analysis of Group 2 vs Group 3 in that there was no difference in GS and PC (P ¼ 0.95 and 0.75, respectively). Unlike Group 1, however, there was no difference in DR (P ¼ 0.88). The PT remained significantly lower in the telephone consultation (Po0.01). Duration of consult and wait times were both significantly longer in Group 2 compared with the telephone group (Po0.01).
We then looked at the comparison between Groups 1 and 2. We found that there was no difference between the two in terms of GS and PC (P ¼ 0.70 and 0.89, respectively); however, somewhat unexpectedly the DR was significantly higher in Group 1 (P ¼ 0.02). There was no difference in PT between the two groups (P ¼ 0.12). As expected, significantly more people were examined in Group 2 compared with Group 1 (Po0.01). Although there was no difference in waiting time between the two groups (P ¼ 0.48), the mean duration of consultation was significantly longer in Group 2 (Po0.01).
Finally, we had a cohort of 50 patients who attended both the outpatient clinic and undertook the telephone consultation and had completed two questionnaires. Of these 50 patients, 14 were common to Groups 1 and 3 and the remaining 36 were common to Groups 2 and 3. In total, 11 (22%) men had been treated with DXT, 12 (24%) with radical prostatectomy, eight (16%) were on active surveillance and 19 (38%) had been treated with hormones initially. We found no significant difference in any of the four domains between the two consultations (GS, P ¼ 0.43; PC, P ¼ 0.76; DR, P ¼ 0.58; and PT, P ¼ 0.43). There was no difference in duration of consultation (P ¼ 0.20), but the waiting time was significantly shorter in the telephone group (Po0.01).
Discussion
Our results show that there was no significant difference between telephone consultations and face-to-face ap- Patient satisfaction with nurse-led telephone consultation N Shaida et al pointments in terms of GS and PC. However, patients were significantly less satisfied in terms of DR (for Group 1 only) and PT. The findings are not entirely surprising given that the telephone consultations were significantly shorter than their face-to-face equivalents, and it may be difficult to establish the DR in a telephonebased consultation, given the lack of audiovisual cues that are present in face-to-face consultation. Nevertheless, it is encouraging that GS and PC are not impaired by telephone consultations; indeed, the mean score for GS was marginally higher in telephone consultations. The most common reasons for patients being asked to return to an outpatient clinic from a telephone clinic by a clinician included sudden PSA rises that would necessitate a treatment change, new neurological or urological symptoms, uncertainty in whether the patient or his family understood the nature of their treatment, patients with non-PSA-secreting tumours and those who were otherwise deemed to require physical examination. Patient requests for outpatient consultation were most commonly due to worsening symptoms followed by a rising PSA. Interestingly, a higher proportion of patients who had been initially treated with hormone therapy were seen in the outpatient clinic once the telephone clinic had started compared with those seen in outpatients before commencement of the telephone clinic. This may reflect later stage disease causing more problems for the patient and necessitating more regular examination and assessment.
The telephone consultations were significantly shorter than their outpatient equivalents and the waiting times were significantly shorter. In terms of convenience, a not inconsiderable proportion of patients reported that they found the trip (or would find in the case of the telephone group) inconvenient. Many of the concerns filled in on the comments section of the questionnaire related to traffic and parking concerns (exacerbated in our case by the fact that our hospital is close to the town centre). Most of the remainder of the feedback in the comments section was extremely positive.
As we expected, less than 10% of patients attending outpatients before commencing telephone consultations required examination. This figure then rose to 37% after the telephone consultations had started reflecting the use of the telephone service as a screening tool to pick out potential problems. The mean duration of outpatient consultation was significantly longer after the telephone consultation had started. This was probably as a result of firstly more complicated patients being seen in the outpatients department, and secondly more time being available to the clinician to review the patient.
In conclusion, it is our experience that telephone consultations for the follow-up of patients with prostate cancer are generally acceptable to patients; however, there is a loss in DR and PT spent with the clinician. These losses are balanced by significantly shorter waiting times and the removal of what is sometimes a long and inconvenient journey. The use of telephone consultations has enabled us to spend more time with more complicated patients in the outpatient department. At the moment, email consultations are not a viable alternative as a relatively small proportion of patients have access.
The majority of the telephone consultations were carried out by uro-oncology nurse specialists, and the acceptability of telephone consultations reflects the important role that they play in the management of prostate cancer patients.
